Cardiology Update

JANUARY 24, 2024

Growing Global Burden of Cardiometabolic Risks: The 2023 World Obesity Atlas projects a significant rise in global overweight and obesity levels by 2035, leading to a surge in diabetes cases. The findings have significant implications for clinical and public health practice and research.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

DAIC

MARCH 8, 2024

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111

Obesity Heart Disease Heart attacks Heart Attack 111

Stroke Journal

FEBRUARY 1, 2024

Conclusion:The global burden of stroke attributable to high BMI in OECD countries highlights the urgent need for comprehensive strategies to address the intertwined challenges of obesity and stroke. Result:The total number of deaths saw a decline from 148,031 (95%UI 85,206-219,328) in 1990 to 143,105 (95%UI: 85,383-209,533) in 2019.

BMI 40

BMI Stroke Strokes Obesity 40

DAIC

MARCH 5, 2024

They adjusted for the participants' use of tobacco and other characteristics, including their age, sex, race, body mass index or BMI, obesity, diabetes, physical activity levels, and socioeconomic status. Goff , M.D., director of the NHLBI’s Division of Cardiovascular Sciences.

Heart Attack 98

Heart Attack Heart attacks Stroke Strokes 98